PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
,
Founded in 2015
1-10 employees
PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2015
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- 400 Cypress Ave California South San Francisco
- City
- Region
- Postal Code
- 94080
- Country
- United States
Web Presence
Websiteprimevax.com
LinkedIn0 followers